BPGAM
PCRX icon

BTG Pactual Global Asset Management’s Pacira BioSciences PCRX Stock Holding History

BTG Pactual Global Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,600
Closed -$252K – 212
2014
Q3 		$252K Buy
+2,600
New +$253K 0.03% 189

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BTG Pactual Global Asset Management's PCRX Position: Q4 2014 in Review

BTG Pactual Global Asset Management sold out of Pacira BioSciences (PCRX) in Q4 2014, closing a stake of 2,600 shares — an estimated $252K sold.

BTG Pactual Global Asset Management first reported a position in PCRX in Q3 2014 and held it in 1 quarter. The position peaked at $252K in Q3 2014. 200 funds tracked by Wall St. Rank hold PCRX as of Q4 2014.

  • BTG Pactual Global Asset Management reported no remaining Pacira BioSciences position as of Q4 2014 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 2,600 Pacira BioSciences shares in Q4 2014, an estimated $252K.
  • BTG Pactual Global Asset Management first reported a position in Pacira BioSciences in Q3 2014 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Pacira BioSciences position peaked at $252K in Q3 2014.
  • 200 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2014.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.